Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus and Lyxumia combination effects on insulin secretion and gastric emptying in type 2 diabetes
2013-003171-35Phase 2Completed
- Sponsor
- Profil
- Start
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lixisenatide and insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Profil. Primary endpoint: AUCISEC(0-10min). Started Jul 2013; status: completed.
02
Drugs
lixisenatideinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-003171-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003171-35.